CPD and neoplasm: Similarly, CP-d/n-ATF5 significantly inhibited SK-N-DZ tumor growth over time (Supplementary Fig. S17A and S17B), with a >2-fold decrease in tumor weight at day 40 (Supplementary Fig. S17C).